CoChat

Treatment of Selective Serotonin Reuptake Inhibitor-Resistant Depression in Adolescents: Predictors and Moderators of Treatment Response

Open access
ASARNOW, JOAN ROSENBAUM, EMSLIE, GRAHAM, CLARKE, GREG, WAGNER, KAREN DINEEN, SPIRITO, ANTHONY, VITIELLO, BENEDETTO, IYENGAR, SATISH, SHAMSEDDEEN, WAEL, RITZ, LOUISE, BIRMAHER, BORIS, RYAN, NEAL, KENNARD, BETSY, MAYES, TARYN, DEBAR, LYNN, MCCRACKEN, JAMES, STROBER, MICHAEL, SUDDATH, ROBERT, LEONARD, HENRIETTA, PORTA, GIOVANNA, KELLER, MARTIN, BRENT, DAVID · 2009 · Journal of the American Academy of Child & Adolescent Psychiatry
Cited by 183

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Objective To advance knowledge regarding strategies for treating selective serotonin reuptake inhibitor (SSRI)–resistant depression in adolescents, we conducted a randomized controlled trial evaluating alternative treatment strategies. In primary analyses, cognitive-behavioral therapy (CBT) combined with medication change was associated with higher rates of positive response to short-term (12-week) treatment than medication alone. This study examines predictors and moderators of treatment response, with the goal of informing efforts to match youths to optimal treatment strategies. Method Youths who had not improved during an adequate SSRI trial (N = 334) were randomized to an alternative SSRI, an alternative SSRI plus CBT, venlafaxine, or venlafaxine plus CBT. Analyses examined predictors and moderators of treatment response. Results Less severe depression, less family conflict, and absence of nonsuicidal self-injurious behavior predicted better treatment response status. Significant moderators of response to CBT + medication (combined) treatment were number of comorbid disorders and abuse history; hopelessness was marginally significant. The CBT/combined treatment superiority over medication alone was more evident among youths who had more comorbid disorders (particularly attention-deficit/hyperactivity disorder and anxiety disorders), no abuse history, and lower hopelessness. Further analyses revealed a stronger effect of combined CBT + medication treatment among youths who were older and white and had no nonsuicidal self-injurious behavior and longer prestudy pharmacotherapy. Conclusions Combined treatment with CBT and antidepressant medication may be more advantageous for adolescents whose depression is comorbid with other disorders. Given the additional costs of adding CBT to medication, consideration of moderators in clinical decision making can contribute to a more personalized and effective approach to treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/chi.0b013e3181977476

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Poznanski, 1984, Psychopharmacol Bull, 21, 979

Cited by

See all 183

Metadata

Authors
ASARNOW, J. R., EMSLIE, G., CLARKE, G., WAGNER, K. D., SPIRITO, A., VITIELLO, B., IYENGAR, S., SHAMSEDDEEN, W., RITZ, L., BIRMAHER, B., RYAN, N., KENNARD, B., MAYES, T., DEBAR, L., MCCRACKEN, J., STROBER, M., SUDDATH, R., LEONARD, H., PORTA, G., KELLER, M., & BRENT, D.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2009-03
Volume
48
Issue
3
Pages
330-339
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2087545180
Cited by
183
References
41
FWCI
12.38
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.